Daily news email for March 07, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

Haselmeier Establishes New Pen Injector Assembly Facility in India

Medicyte Now with Online Shop for Upcyte® Hepatocytes and Innovative Cell Products

Genervon to Award Price for Scientists Proposing Medical Indications and Trial Protocols - ...

BioSpace
Conformetrix Appoints Dr Sam Williams as Chief Executive Officer

Novartis AG' Gilenya Pill Loses Market Share as Doctors Become Wary

With the Right Photo, Your Facebook Text Profile Hardly Matters, Ohio State University Study

New Approach for Treating Genetic Muscle Wasting Disease Shows Promise in Mice, University of Ottawa Study

Exercise and Caffeine Change Your DNA in the Same Way, Karolinska Institute Study

BioSpace - Breaking News
Arrowhead Research Corporation Releases White Paper on Hepatitis B Virus and Potential RNAi Treatment

Sucampo Pharmaceuticals, Inc. Release: Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics

Merck & Co., Inc. Release: Results from Investigational Studies with VICTRELIS (boceprevir) Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1

Viral Genetics Inc. Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA

Eisai Inc. Receives Complete Response Letter from the U.S. FDA for Dacogen (decitabine) for Injection sNDA in Acute Myeloid Leukemia

Biotech News - Business Wire
Biomagnetics Provides an Update to its Investors and Shareholders

Medtronic CFO Gary Ellis to Speak at Barclays Capital Global Healthcare Conference

Jim Macemon Joins nanoMR as V.P., Product Development

A TECHINT E&C construirá estabelecimentos para produção do revolucionário bioplástico PHAs concebido pela bio-on

TECHINT E&C to Build Plants for Production of Revolutionary PHAs Bioplastic Designed by bio-on

Biotech News - PR Newswire
First Statewide Biotech Meeting Focuses on Patient Access, Innovation

DuPont Leader Overviews 2012 Seed Research Pipeline with Investors

Be One of the First to Experience Medtrack One View at the AUTM 2012 Annual Meeting

Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial

Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Joint Custody

Bribery a Growing Legal Liability for Big Pharma, says Reuters

Galapagos Scores with Abbott Deal

Shire Inks Antibody Discovery Alliance with arGEN-X

NIH Takes Its Genetic Testing Registry Online

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Stainless Steel Equipment, Storage Systems and Mobile Transport Carts

Myelin Repair Foundation Research Fosters a Clinical Trial for Multiple Sclerosis

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Safety Huber Needles

Ivantis Enrolls First Patient for U.S. Clinical Study on Glaucoma

PSI Announces Revenue and Client Growth for 2011

Clinical Trials - PR Newswire
Molecular Detection Inc. Completes $1.5 Million Financing to Advance New Tests for Sepsis and GI Disorders

Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting

Pycnogenol® (French Maritime Pine Bark Extract) Shown to Improve Menopause Signs and Symptoms in New Clinical Trial

Unlocking Autism's Mysteries: CMU's Marcel Just Uses New Brain Imaging and Computer Modeling to Predict Autistic Brain Activity and Behavior

InspireMD Announces its 2011 Year End Financial Results

CNN Top Stories
New iPad coming

Opinion: No winners

Opinion: NFL fans lust for violence

NFL's Saints admit paying for pain

Ready for a new iPad

Contract Pharma
Almac Expands Commercial Packaging Ops

ASLAN Pharma Selects PharmaNet/i3 as Strategic Partner

Catalent Expands Facilities for Clinical Supply Services

CRL Expands Services in Asia

EntreMed To Open China Office, Ends SVT Alliance

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs

CDER World

Comunicado de la FDA sobre la seguridad de los medicamentos: Reingreso planeado al mercado de CardioGen-82 con nuevo recuadro de advertencia

FDA News - Business Wire
Viral Genetics Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA

Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia

Eisai Inc. Receives Complete Response Letter from U.S. Food and Drug Administration for DACOGEN® (decitabine) for injection sNDA in Acute Myeloid Leukemia

Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter

Crosstrees Medical, Inc. Completes Enrollment of USA IDE Study for Percutaneous Vertebral Augmentation (PVA)

FDA Press Releases
FDA approves Surfaxin to prevent breathing disorder in premature infants

FDA issues warning letter to makers of AeroShot caffeine inhaler

FDA issues warning letter to makers of AeroShot “caffeine inhaler”

La FDA anuncia modificaciones relacionadas con la seguridad en las indicaciones de algunos medicamentos que reducen el colesterol

FDA approves two new pancreatic enzyme products to aid food digestion

FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

FierceBiotech
CNS drug developers face long stretch in the clinic, poor odds of success

Positive Phase III sets stage for levomilnacipran NDA

Fresh woes for Gilead as two more hep C patients relapse in small 7977 study

Mersana snaps up $270M cancer drug deal with Endo Pharma

Tufts: CNS drug developers face long stretch in the clinic, poor odds of success

FierceBiotech IT
Ex-NCI cancer informatics chief lands at ASU

FDA calls out Biochem for IT no-nos

Reuters advances life sciences informatics platform

Social media jump-starts stalled patient recruitment efforts

NIH backs effort to integrate clinical trials data into EHRs

FierceBiotech Research
Beefed-up FAK protein slashed heart attack damage in mice

UPDATED: UCLA's 'molecular tweezers' dismantles Parkinson's in zebra fish

Breakthrough IDs possible liver repair process

The battle to halt Alzheimer's may come down to sugar

UPDATED: UCLA's 'molecular tweezers' dismantles Parkinson's in zebrafish

FiercePharma
Pradaxa patient's death draws more scrutiny of bleeding risks

Whistleblower claims Takeda blunted Actos heart reports

AZ mulls buy-or-sell options for Indian unit

Roche can shop around if Illumina bid fails, Humer says

Shire pits Vyvanse against Concerta in ADHD trials

FiercePharma Manufacturing
FDA cites Gulf Pharmaceutical for predating documentation

GlaxoSmithKline, Daiichi Sankyo join forces to sell vaccines in Japan

Boehringer Ingelheim spends 17M on expansion in Germany, Vienna

AmerisourceBergen buys another pharmaceutical services company

India's Emcure to manufacture Roche's Herceptin, MabThera

FierceVaccines
UPDATED: Getting under the skin of vaccines

AstraZeneca's FluMist Quadrivalent to hit U.S. market

Getting under the skin of vaccines

Inactivated polio vaccine reaches Nigeria

Bacteria may lead to HIV vaccine

Health News - BizJournals.com
Kansas Bioscience Authority approves $3.3M in investments

Nuance to pay $300M for latest health IT acquisition

Rusnano, Domain Associates sign investment agreement

Colleges, employers ask for Facebook passwords

Leesburg historic site impacts possible nursing home

Health News - CNBC
6 execs charged in Olympus loss coverup scandal

Snoring tied to kids' risk of behavioral problems: study

The Future of Illumina

Dusa Pharma jumps following strong 4Q sales

FDA approves Discovery Lab's lung drug

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Aragon Raises $42M to Progress Prostate and Breast Cancer Drugs

GE Healthcare to Snag Xcellerex for Single-Use Manufacturing Technology

Alverix Continues Expansion of Its Intellectual Property Portfolio with the Addition of Two Key Patents

USPTO Rejects Butamax's Self-Described Foundational IP Claims in Successful Gevo Reexamination Petition

Russian Tech Fund Joins U.S. VC Firm in $760M Biopharma Venture

Marketwire - Pharma and Biotech
Tissue Diagnostics Leads Personalized Medicine: Kalorama

International Drug & Explosives Detection Company IDenta Corp. Announces Strategic Alliance With an American Company

Personalized Medicine: New Dot Com Craze

Multinational Pharmaceutical Upgrades Mobility Sales Force Efficiency With StayinFront

CytoSorbents to Exhibit and Host Research Symposium at Major International Critical Care Conference

MassBio News
MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

MassBio's Peter Abair discusses growth in the cluster with US Building Digest

MassBio Purchasing Consortium Augments Four Major Agreements

Medical Pharma - PR Newswire
Millennium HealthCare Appoints Ed Joyce to Company Advisory Board

Michael Milken Joins Focused Ultrasound Foundation Council

Key Leadership Appointments Announced at Scott & White Healthcare

Foundation Challenges African Physicians from 17 Countries to Implement Regional "Call to Action"

La JMF demande aux médecins africains issus de 17 pays de se mobiliser et de répondre à l'« Appel à l'action » pour leur continent

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
OpenVigilfree eyeballs on AERS pharmacovigilance data

The blinded buyer

Planning for the exit

PRIDE Inspector: a tool to visualize and validate MS proteomics data

2011Big biotechs gorge on debt

New York Times- Biotechnology
Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

New York Times- Pharmaceuticals
F.D.A. Issues New Alerts About Cholesterol Drugs

F.D.A. Backs Respiratory Distress Drug For Babies

Pay Only for Drugs That Help You

AARP Study Says Price of Popular Drugs Rose 26%

F.D.A. Backs Surfaxin, Respiratory Distress Drug For Babies

OnBioVC
Warp Drive Bio, LLC: Series A $75M

GlySure, Ltd.: Series C $10.9M

Aria Diagnostics, Inc.: Series C $52.7M

Avinger, Inc.: Series C $22.5M

RaNA Therapeutics, Inc.: Series A $20.7M

Outsourcing-Pharma
Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Pharma News - Business Wire
Alliance for Advanced Therapies to officially launch at BIO-Europe Spring® 2012

Revitas Validata Breaks Down Big Data to Reduce Margin Erosion in Pharma Companies

Samenvatting: Alliantie voor Geavanceerde Therapieën (AAT) wordt officieel op de BIO-Europe Spring 2012 gelanceerd

GE Healthcare To Acquire Xcellerex Inc., Broadening Capabilities in Growing Biopharmaceutical Manufacture Segment

Resumen: La Alianza para Terapias Avanzadas se lanzará oficialmente en BIO-Europe Spring® 2012

Pharma News - PharmiWeb
m.powerment by mark. Reaches $1 Million in Funds Raised

Media Alert: Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN® (lucinactant)

Roche Annual General Meeting 2012

Enhanced facilities spur the drive of emerging technologies

Stratedigm announces the launch of the A600 High Throughput Auto Sampler with Flat-6 Technology TM

Pharma News - PR Newswire
SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization

Four Independent Pharmacies Sue HHS and CMS for Violating Medicare Part D Law By Allowing Drug Plans To Establish Cartels With Big Box Retailers

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx

Abbott to Present at Barclays Capital 2012 Global Healthcare Conference

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Cayman Enterprise City, a Technology-based Special Economic Zone,...

Lab Automation University Online Launches Latest Webinar Series

Merrill Brink Releases New Comments - Quality Medical Translation will...

4s3 Bioscience, Inc. Secures $20M in Series A Financing

BioPharm Systems Launches Accel-Account Manager for Creating and...

PRWeb - Pharmaceuticals
Global Herbal Supplements and Remedies Market to Reach US$107 Billion...

Global Foot Care Products Market to Reach US$3.53 Billion by 2017,...

Actos Litigation Update Provided by Actos Lawsuit Attorney- Rudolph...

Interesting Tinnitus Studies, Statistics, and Facts Now Available at...

Diminished Ovarian Reserve Expert Releases Tip Sheet for Timely...

Scientific American
9 Flying Robots Play 007 Theme

Raise It or Raze It: How Will the Stranded Italian Cruise Ship Be Salvaged

Could a Penny Dropped Off a Skyscraper Actually Kill You

Industrial Chemicals Linked to Attention Problems in Children

Nine Flying Robots Play 007 Theme

Sports - ESPN Basketball
Legends Classic sets regional hosts for 2012

Ex-Kansas great Lewis dies after cancer fight

S. Dakota State earns 1st NCAA tourney berth

Detroit captures Horizon League title, NCAA bid

Harvard nets first NCAA tourney bid since 1946

Sports News - ESPN
Gundy says Harrison has left Oklahoma State

Gators paying new O coaches more than $2M

Alabama RB Lacy, OL Kouandjio out for spring

Wojciechowski: Barkley happy to return to USC

USC says FB/LB Vehikite is no longer on team

Xconomy Life Sciences
Molecular Health Sets up in NYC With Personalized Med Tools

How Biogen Idec Overhauled R&D Under Doug Williams

BG Medicine, Bottomline, 4s3 Bioscience Among the Week's Dealmakers

Qualcomm's Irwin Jacobs Becomes CEO Emeritus, 20 Years After IPO

Disease Foundations Play Growing Role in Biotech Business Model

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)